You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
培力農本方(01498.HK)業績:上半年純利1197.4萬港元,濃縮中藥配方顆粒銷售業務反彈
格隆匯 08-20 21:12

格隆匯8月20日丨培力農本方(01498.HK)公佈中期業績,截至2021年6月30日止6個月,公司實現總收益3.03億港元,同比增長7.96%;母公司擁有人應占期內溢利1197.4萬港元,同比增長4.70%,基本每股盈利3.04港仙。

該純利主要受中國濃縮中藥配方顆粒銷售反彈所帶動及部分歸因於所收取的中國政府補貼所致。在不計入2021年及2020年中期期間有關非經常性政府補貼的情況下,則集團於2021年中期期間將錄得經營溢利,並自2020年中期期間錄得的經營虧損轉虧為盈。

於2021年中期期間,濃縮中藥配方顆粒於中國的銷售額為1.569億港元,較去年同期的1.215億港元增加3540萬港元或29.1%。由於自2021年年初COVID-19疫症整體而言得到控制,中國政府已逐步放寬防控COVID-19的措施,有關措施包括旅遊限制、區域封鎖以及暫時關閉部分中醫診所及醫院,而促使消費者活動回到正常層面。因此,中國濃縮中藥配方顆粒銷售業務反彈,尤其是於2021年第一季度。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account